© 2021 MJH Life Sciences and Cure Today. All rights reserved.
© 2021 MJH Life Sciences™ and Cure Today. All rights reserved.
June 15, 2021
Treatment with pyrotinib and the chemotherapies trastuzumab, docetaxel and carboplatin significantly improved response rates over the triplet chemotherapy regimen alone in the neoadjuvant treatment of patients with HER2-positive breast cancer.
Tobacco Use May Worsen MPN Symptoms
Metastatic Breast Cancer: We Are the Cheated
3 Ways to Get Cancer Off Your Back
Pregnant Women With Previous or Current Cancer Diagnoses May Experience More Complications During Delivery